Financials

  • Market Capitalization 30.88 M
  • Employee N/A
  • Founded 2006
  • CEO N/A
  • Website www.estrellabio.com
  • Headquarter California, United States
  • FIGI BBG00ZDR7G05
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.46
Price to sales ratio
41.03

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4437
IGC
IGC Pharma, Inc. Common Stock
0.31 USD-6.06%+3.33%+24.00%+21.00%32.05 M USD
4441
ATNM
Actinium Pharmaceuticals, Inc. Common Stock
1.01 USD-0.98%-5.61%+20.24%-2.88%31.76 M USD
4449
BRNS
Barinthus Biotherapeutics plc - American Depositary Shares
0.75 USD0.00%+19.05%+36.36%-39.02%30.64 M USD
4470
GRDX
GridAI Technologies Corp. - Common Stock
3.96 USD-1.25%+17.16%+54.69%+55.29%28.24 M USD

Frequently asked questions about Estrella Immunopharma, Inc. Common Stock

What is the Estrella Immunopharma, Inc. Common Stock stock price today?

The current price of Estrella Immunopharma, Inc. Common Stock (ESLA) is 0.71. Over the past 24 hours, the stock has changed by -1.39%. Follow the ESLA chart for real-time price dynamics.

What is the stock ticker of Estrella Immunopharma, Inc. Common Stock?

Estrella Immunopharma, Inc. Common Stock trades under the ticker ESLA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Estrella Immunopharma, Inc. Common Stock stock going up?

ESLA has changed by -6.58% over the last week, -6.58% over the last month, and -33.02% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Estrella Immunopharma, Inc. Common Stock?

Estrella Immunopharma, Inc. Common Stock currently has a market capitalization of 30.88 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Estrella Immunopharma, Inc. Common Stock earnings last quarter?

Last quarter, Estrella Immunopharma, Inc. Common Stock reported earnings of -0.05 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Estrella Immunopharma, Inc. Common Stock revenue for the last quarter?

Estrella Immunopharma, Inc. Common Stock reported quarterly revenue of -1.8 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Estrella Immunopharma, Inc. Common Stock net income for the last quarter?

Estrella Immunopharma, Inc. Common Stock reported net income of -2.31 M for the last quarter. The previous quarter showed -2.29 M, which means net income changed by -0.62%.

How can I buy Estrella Immunopharma, Inc. Common Stock stock?

You can buy Estrella Immunopharma, Inc. Common Stock (ESLA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Estrella Immunopharma, Inc. Common Stock stock?

Investing in Estrella Immunopharma, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ESLA chart and related analysis on metatrader.com as part of your research.

News